NCT00401947View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection

PHASE2TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

March 31, 2007

Conditions
HCV Infection
Interventions
DRUG

ACH-0137171

Trial Locations (9)

10029

Clinical Trial Site, New York

75208

Clinical Trial Site, Dallas

78215

Clinical Trial Site, San Antonio

85054

Clinical Trial Site, Phoenix

92093

Clinical Trial Site, La Jolla

94143

Clinical Trial Site, San Francisco

02215

Clinical Trial Site, Boston

BE 14050

Clinical Trial Site, Berlin

6584 CX

Clinical Trial Site, Utrecht

Sponsors
All Listed Sponsors
collaborator

Achillion, a wholly owned subsidiary of Alexion

INDUSTRY

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY